News

Video | Proactive Biosciences Webinar

Sep 28, 2021

Video | Proactive Biosciences Webinar

Register To Attend | Proactive Biosciences Webinar

Sep 23, 2021

Register To Attend | Proactive Biosciences Webinar

Investor Webinar | Drug Development Programs and Overview

Aug 24, 2021

Investor Webinar | Drug Development Programs and Overview

Investor Webinar | Emyria validated care model

Jun 09, 2021

Investor Webinar | Emyria validated care model

Health Europa E-Book

Apr 30, 2021

Health Europa E-Book

Investor Webinar | Emyria and Cann Group Partnership

Apr 09, 2021

Investor Webinar | Emyria and Cann Group Partnership

Emyria and Cann Group to partner on Schedule 3 medicine CBD product registration

Mar 28, 2021

Emyria and Cann Group to partner on Schedule 3 medicine CBD product registration

Opinion | Psychedelic substances represent a chance to alleviate Australia’s mental health crisis

Mar 20, 2021

Opinion | Psychedelic substances represent a chance to alleviate Australia’s mental health crisis

Presentation: Dr Michael Winlo on Broker Briefing

Mar 16, 2021

Presentation: Dr Michael Winlo on Broker Briefing

Contact Us

Phone 1300 436 363

Email info@emyria.com

Recent Tweets

MD, mwinlo presented at the proactive_au Lifesciences webinar and we are pleased to provide Investors and Shareho… https://t.co/djSSU6jgpl

MD, mwinlo will be presenting at the proactive_au Lifesciences webinar. Emyria will be one of three companies p… https://t.co/4RVxWyMvj6

MD, mwinlo will be presenting at the proactive_au Lifesciences webinar. Emyria will be one of three companies p… https://t.co/0VmEPaSWWH